Minimising antibiotic resistance

Lancet Infectious Diseases

Volumn 5, Issue 7, 2005, Pages 450-459

  Livermore, David M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTOBIPROLE; CEPHALOSPORIN; CHLORAMPHENICOL; DALBAVANCIN; DALFOPRISTIN; ERYTHROMYCIN; FOSFOMYCIN; GEMIFLOXACIN; IMIPENEM; LINEZOLID; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; NITROFURANTOIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TAZOBACTAM; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; BACTEREMIA; CLINICAL TRIAL; DIARRHEA; DRUG COST; DRUG EFFECT; ECOLOGY; EUROPE; GONORRHEA; GOVERNMENT; HUMAN; INCIDENCE; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 20544434124     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70166-3     Document Type: Note

References (85)

1. RG Finch, JP Metlay, PG Davey, LJ Baker Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002 Lancet Infect Dis 4 2004 44 53
2. MH Kollef The importance of appropriate initial antibiotic therapy for hospital-acquired infections Am J Med 115 2003 582 84
3. EH Ibrahim, G Sherman, S Ward, VJ Fraser, MH Kollef The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Chest 118 2000 146 55
4. DM Mosdell, DM Morris, A Voltura Antibiotic treatment for surgical peritonitis Ann Surg 214 1991 543 49
5. SD Reed, JY Friedman, JJ Engemann Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia Infect Control Hosp Epidemiol 26 2005 175 83
6. BJ Kopp, DE Nix, EP Armstrong Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections Ann Pharmacother 38 2004 1377 82
7. VM Hughes, N Datta Conjugative plasmids in bacteria of the 'pre-antibiotic' era Nature 302 1983 725 26
8. HY Chen, M Yuan, IB Ibrahim-Elmagboul, DM Livermore National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa J Antimicrob Chemother 35 1995 521 34
9. SL Bronzwaer, O Cars, U Buchholz A European study on the relationship between antimicrobial use and antimicrobial resistance Emerg Infect Dis 8 2002 278 82
10. JW Chow, MJ Fine, DM Shlaes Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy Ann Intern Med 115 1991 585 90
11. BA Oppenheim The changing pattern of infection in neutropenic patients J Antimicrob Chemother 41 suppl D 1998 7 11
12. R Wise The relentless rise of resistance? J Antimicrob Chemother 54 2004 306 10
13. H Goossens, M Ferech, SR Vander, M Elseviers Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 365 2005 579 87
14. LF McCaig, RE Besser, JM Hughes Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000 Emerg Infect Dis 9 2003 432 37
15. GE Smith, S Smith, H Heatlie What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report? Description of trends in antimicrobial usage using the General Practice Research Database J Public Health (Oxf) 26 2004 359 64
16. DM Fleming, AM Ross, KW Cross, H Kendall The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing Br J Gen Pract 53 2003 778 83
17. D Livermore Can better prescribing turn the tide of resistance? Nat Rev Microbiol 2 2004 73 78
18. R Reynolds, J Shackcloth, D Felmingham, A MacGowan Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme J Antimicrob Chemother 52 2003 931 43
19. DB Price, D Honeybourne, P Little Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice Respir Med 98 2004 17 24
20. P Davey, P Donnan, D Fleming, R Wise, M Woodhead Association between antibiotic prescribing trends in general practice and community-acquired pneumonia mortality Respir Med 98 2004 798 800
21. DM Livermore, D James, MH Reacher Trends in fluoroquinolone (ciprofloxacin) resistance among Enterobacteriaceae from bacteremias in England and Wales, 1990-1999 Emerg Infect Dis 8 2002 473 78
22. PA Bradford Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat Clin Microbiol Rev 14 2001 933 51
23. M Yuan, H Aucken, LM Hall, TL Pitt, DM Livermore Epidemiological typing of klebsiellae with extended-spectrum β-lactamases from European intensive care units J Antimicrob Chemother 41 1998 527 39
24. L Poirel, P Kampfer, P Nordmann Chromosome-encoded Ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases Antimicrob Agents Chemother 46 2002 4038 40
25. N Woodford, ME Ward, ME Kaufmann Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK J Antimicrob Chemother 54 2004 735 43
26. CJ Munday, GM Whitehead, NJ Todd, M Campbell, PM Hawkey Predominance and genetic diversity of community and hospital acquired CTX-M extended-spectrum β-lactamases in York, UK J Antimicrob Chemother 54 2004 628 33
27. A Valverde, TM Coque, MP Sanchez-Moreno, A Rollan, F Baquero, R Canton Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain J Clin Microbiol 42 2004 4769 75
28. H Seppala, T Klaukka, J Vuopio-Varkila The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland N Engl J Med 337 1997 441 46
29. J Kataja, P Huovinen, A Muotiala Clonal spread of group A streptococcus with the new type of erythromycin resistance J Infect Dis 177 1998 786 89
30. M Bergman, S Huikko, M Pihlajamaki Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001 Clin Infect Dis 38 2004 1251 56
31. M Pihlajamaki, J Jalava, P Huovinen, P Kotilainen Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000 Antimicrob Agents Chemother 47 2003 1832 35
32. VI Enne, DM Livermore, P Stephens, LM Hall Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction Lancet 357 2001 1325 28
33. YF Chiew, SF Yeo, LM Hall, DM Livermore Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae J Antimicrob Chemother 41 1998 247 51
34. VI Enne, PM Bennett, DM Livermore, LM Hall Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure J Antimicrob Chemother 53 2004 958 63
35. FM Aarestrup, AM Seyfarth, HD Emborg, K Pedersen, RS Hendriksen, F Bager Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark Antimicrob Agents Chemother 45 2001 2054 59
36. OE Heuer, K Pedersen, JS Andersen, M Madsen Vancomycin-resistant enterococci (VRE) in broiler flocks 5 years after the avoparcin ban Microb Drug Resist 8 2002 133 38
37. EJ Pleydell, E Snary, F Clifton-Hadley The effect of different management systems on levels of resistant bacteria isolated on pig and poultry farms Res Vet Sci 74 suppl A 2003 4
38. DM Livermore, M Warner, LM Hall Antibiotic resistance in bacteria from magpies (Pica pica) and rabbits (Oryctolagus cuniculus) from west Wales Environ Microbiol 3 2001 658 61
39. MA Gilliver, M Bennett, M Begon, SM Hazel, CA Hart Antibiotic resistance found in wild rodents Nature 401 1999 233 34
40. BR Levin, V Perrot, N Walker Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria Genetics 154 2000 985 97
41. DE Rawlings Proteic toxin-antitoxin, bacterial plasmid addiction systems and their evolution with special reference to the pas system of pTF-FC2 FEMS Microbiol Lett 176 1999 269 77
42. DL Paterson "Collateral damage" from cephalosporin or quinolone antibiotic therapy Clin Infect Dis 38 suppl 4 2004 S341 45
43. S Harbarth, S Cosgrove, Y Carmeli Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci Antimicrob Agents Chemother 46 2002 1619 28
44. CD Settle, MH Wilcox, WN Fawley, OJ Corrado, PM Hawkey Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam Aliment Pharmacol Ther 12 1998 1217 23
45. AP Johnson, H Aucken, S Cavendish Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: Analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS) J Antimicrob Chemother 48 2001 143 44
46. DL Paterson, WC Ko, A Von Gottberg Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory J Clin Microbiol 39 2001 2206 12
47. GS Babini, DM Livermore Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998 J Antimicrob Chemother 45 2000 183 89
48. JW Beaber, B Hochhut, MK Waldor SOS response promotes horizontal dissemination of antibiotic resistance genes Nature 427 2004 72 74
49. MJ Schofield, P Hsieh DNA mismatch repair: molecular mechanisms and biological function Ann Rev Microbiol 57 2003 579 608
50. A Oliver, R Canton, P Campo, F Baquero, J Blazquez High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection Science 288 2000 1251 54
51. J Blazquez, A Oliver, JM Gomez-Gomez Mutation and evolution of antibiotic resistance: antibiotics as promoters of antibiotic resistance? Curr Drug Targets 3 2002 345 49
52. C Ramsay, E Brown, G Hartman, P Davey Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing J Antimicrob Chemother 52 2003 764 71
53. F Ansari, K Gray, D Nathwani Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis J Antimicrob Chemother 52 2003 842 48
54. U Stiefel, DL Paterson, NJ Pultz, SM Gordon, DC Aron, CJ Donskey Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers Infect Control Hosp Epidemiol 25 2004 380 83
55. JE Patterson, TC Hardin, CA Kelly, RC Garcia, JH Jorgensen Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae Infect Control Hosp Epidemiol 21 2000 455 58
56. MJ Schwaber, CS Graham, BE Sands, HS Gold, Y Carmeli Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species Antimicrob Agents Chemother 47 2003 1882 86
57. JJ Rahal, C Urban, D Horn Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA 280 1998 1233 37
58. DM Livermore, AM Sefton, GM Scott Properties and potential of ertapenem J Antimicrob Chemother 52 2003 331 44
59. SJ Bradley, AL Wilson, MC Allen, HA Sher, AH Goldstone, GM Scott The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage J Antimicrob Chemother 43 1999 261 66
60. LB Rice, R Hutton-Thomas, V Lakticova, MS Helfand, CJ Donskey β-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci J Infect Dis 189 2004 1113 18
61. Friedland I, Shivaprakash M, Giezek H, Motyl M, DiNubile MJ, Chan C., Emergence of resistant gram-negative bacilli in the bowel of patients treated with ceftriaxone/metronidazole vs. Ertapenem for intra-abdominal infections. 3rd International Meeting on Antimicrobial Chemotherapy in Clinical Practice; Santa Margherita, Portofino, Italy; Oct 16-19, 2003. Abstract 30
62. LJ Piddock, DJ Griggs Selection and characterization of cefepime-resistant gram-negative bacteria J Antimicrob Chemother 28 1991 669 76
63. K Drlica The mutant selection window and antimicrobial resistance J Antimicrob Chemother 52 2003 11 17
64. JM Blondeau, G Hansen, K Metzler, P Hedlin The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration J Chemother 16 suppl 3 2004 1 19
65. HJ Smith, KA Nichol, DJ Hoban, GG Zhanel Stretching the mutant prevention concentration (MPC) beyond its limits J Antimicrob Chemother 51 2003 1323 25
66. BS Burleson, DJ Ritchie, ST Micek, WM Dunne Enterococcus faecalis resistant to linezolid: case series and review of the literature Pharmacotherapy 24 2004 1225 31
67. P Wilson, JA Andrews, R Charlesworth Linezolid resistance in clinical isolates of Staphylococcus aureus J Antimicrob Chemother 51 2003 186 88
68. DM Livermore Linezolid in vitro: mechanism and antibacterial spectrum J Antimicrob Chemother 51 suppl 2 2003 9 16
69. KS Kaye, S Cosgrove, A Harris, GM Eliopoulos, Y Carmeli Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp Antimicrob Agents Chemother 45 2001 2628 30
70. MH Kollef Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 29 suppl 4 2001 N135 42
71. CT Bergstrom, M Lo, M Lipsitch Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals Proc Natl Acad Sci USA 101 2004 13285 90
72. EM Brown, D Nathwani Antibiotic cycling or rotation: a systematic review of the evidence of efficacy J Antimicrob Chemother 55 2004 6 9
73. HJ van Loon, MR Vriens, AC Fluit Antibiotic rotation and development of Gram-negative antibiotic resistance Am J Respir Crit Care Med 171 2005 480 87
74. KA Fenton, C Ison, AP Johnson Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002 Lancet 361 2003 1867 69
75. JM Blondeau A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones' J Antimicrob Chemother 43 suppl B 1999 1 11
76. U Kastner, JP Guggenbichler Influence of macrolide antibiotics on promotion of resistance in the oral flora of children Infection 29 2001 251 56
77. M Woodhead, J Macfarlane Local antibiotic guidelines for adult community-acquired pneumonia (CAP): a survey of UK hospital practice in 1999 J Antimicrob Chemother 46 2000 141 43
78. CA Ison, JW Mouton, K Jones, KA Fenton, DM Livermore Which cephalosporin for gonorrhoea? Sex Trans Infect 80 2004 386 88
79. JE Corkill, AJ Komolafe, TJ Neal, A Mortimore, AB Alawattegama, CA Hart Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool Int J STD AIDS 14 2003 379 85
80. SJ Projan Why is big Pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 6 2003 427 30
81. AF Boggs, GH Miller Antibacterial drug discovery: is small pharma the solution? Clin Microbiol Infect 10 suppl 4 2004 32 36
82. DM Livermore Threat from the pink corner Ann Med 35 2003 226 34
83. SR Norrby, CE Nord, R Finch Lack of development of new antimicrobial drugs: a potential serious threat to public health Lancet Infect Dis 5 2005 115 19
84. Infectious Diseases Society of America Bad drugs, no drugs. As antibiotic discovery stagnates... a public health crisis brews http://www.idsociety.org/ pa/IDSA_Paper4_final_web.pdf (accessed May 24, 2005)
85. SJ Projan, DM Shlaes Antibacterial drug discovery: is it all downhill from here? Clin Microbiol Infect 10 suppl 4 2004 18 22